Market Insights Health OTC Pharmaceuticals

Analgesics - Netherlands

Netherlands

In the Netherlands, the revenue in the Analgesics market is estimated to reach €195.60m in 2024.
It is projected that the market will experience an annual growth rate of 4.62% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue in this market, with €6,716.00m in 2024.
Taking into account the total population, the per person revenue in the Netherlands is €11.07 in 2024.
The Netherlands is experiencing a growing demand for natural and herbal analgesics in the OTC Pharmaceuticals market.

Key regions: Brazil, Europe, Germany, Canada, United States

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Analgesics market in Netherlands has been experiencing steady growth in recent years.

Customer preferences: Customers in Netherlands have shown a strong preference for over-the-counter analgesic products. This is driven by the convenience and accessibility of these products, as well as the increasing awareness of self-care and self-medication. Moreover, customers in Netherlands are increasingly seeking natural and organic analgesic products, reflecting a growing trend towards health and wellness.

Trends in the market: One of the key trends in the Analgesics market in Netherlands is the rising demand for non-opioid analgesics. This can be attributed to the growing concerns over the addictive properties and side effects of opioid-based pain medications. As a result, customers are seeking alternative pain relief options that are safer and have fewer adverse effects.Another trend in the market is the increasing popularity of topical analgesics. These products are applied directly to the skin and provide localized pain relief. They are preferred by customers who want targeted pain relief without the systemic effects of oral analgesics. The convenience and ease of application of topical analgesics also contribute to their rising popularity.

Local special circumstances: The Netherlands has a well-developed healthcare system that emphasizes patient empowerment and self-care. This has created a favorable environment for the growth of the Analgesics market, as customers are encouraged to take responsibility for their own health and well-being. The country also has a high level of health literacy, with customers being well-informed about different treatment options and actively seeking out products that align with their preferences and values.

Underlying macroeconomic factors: The strong economic performance of Netherlands has played a significant role in the growth of the Analgesics market. With a stable economy and high disposable incomes, customers have the financial means to purchase analgesic products. Moreover, the aging population in Netherlands has contributed to the increasing demand for analgesics, as older individuals are more likely to experience chronic pain and require pain management solutions.In conclusion, the Analgesics market in Netherlands is experiencing steady growth driven by customer preferences for over-the-counter products, the rising demand for non-opioid analgesics, and the increasing popularity of topical analgesics. The local special circumstances, such as the emphasis on self-care and the high level of health literacy, further support the growth of the market. Additionally, the strong macroeconomic factors, including the stable economy and aging population, contribute to the increasing demand for analgesic products in Netherlands.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.